Life Sciences
The research in the Life Sciences category spans a wide range of sectors related to, and driven by, the biological sciences. This range runs from basic laboratory research tools and services through applications in medicine, agriculture, and even some aspects of environmental and materials sectors. Our market research reports cover the Biotechnology, Pharmaceuticals, Diagnostics, Healthcare, and Medical Devices industries, offering in-depth analysis of markets, trends, and competitors.
By far the biggest industries in the life sciences category are related to human healthcare, including pharmaceuticals; diagnostics; medical devices; and healthcare facilities, delivery, policy and financing. Although heavily regulated in most parts of the globe, human healthcare continues to be a high-growth and often high-margin sector driven by technological innovation, ever-increasing demand, and well-developed funding and public sector support. It is not unusual for breakthrough products in this sector to experience explosive double- and triple-digit growth in their early years, and even products and services that are mere commodities in other markets can find premium value when associated with clinical applications. Despite this luring promise, the complex regulatory, technological, and financial dynamics of this sector make it one of the most challenging to manufacturers and marketers.
By far the biggest industries in the life sciences category are related to human healthcare, including pharmaceuticals; diagnostics; medical devices; and healthcare facilities, delivery, policy and financing. Although heavily regulated in most parts of the globe, human healthcare continues to be a high-growth and often high-margin sector driven by technological innovation, ever-increasing demand, and well-developed funding and public sector support. It is not unusual for breakthrough products in this sector to experience explosive double- and triple-digit growth in their early years, and even products and services that are mere commodities in other markets can find premium value when associated with clinical applications. Despite this luring promise, the complex regulatory, technological, and financial dynamics of this sector make it one of the most challenging to manufacturers and marketers.
Page 28/28
Idenix Pharmaceuticals, Inc. - SWOT, Strategy and Corporate Finance Report
December 2012 · MarketLine
Idenix Pharmaceuticals, Inc. - SWOT, Strategy and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings, etc. € 129,00
Idenix Pharmaceuticals, Inc. - SWOT, Strategy and Corporate Finance Report
December 2012 · MarketLine
Idenix Pharmaceuticals, Inc. - SWOT, Strategy and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings, etc. € 129,00
Pharmaceuticals: Global Industry Almanac
December 2012 · MarketLine
Pharmaceuticals: Global Industry Almanac is an essential resource for top-level data and analysis covering the Pharmaceuticals industry. It includes detailed data on market size and segmentation, textual analysis of the key trends. € 2.199,00
Pharmaceuticals: Global Industry Guide
December 2012 · MarketLine
Pharmaceuticals: Global Industry Guide is an essential resource for top-level data and analysis covering the Pharmaceuticals: Global Industry Guide industry. It includes detailed data on market size and segmentation, textual analysis of the key trends. € 1.099,00
Pharmaceuticals - BRIC (Brazil, Russia, India, China) Industry Guide
November 2012 · MarketLine
Pharmaceuticals - BRIC (Brazil, Russia, India, China) Industry Guide is an essential resource for top-level data and analysis covering the BRIC (Brazil, Russia, India, China) Pharmaceuticals industry. The report includes easily comparable data on ... € 749,00
Pharmaceuticals - Global Group of Eight (G8) Industry Guide
November 2012 · MarketLine
Pharmaceuticals - Global Group of Eight (G8) Industry Guide is an essential resource for top-level data and analysis covering the Pharmaceuticals industry in each of the G8 (United States, Canada, Germany, France, United Kingdom, Italy, Russia and ... € 1.099,00
Pharmaceuticals - North America (NAFTA) Industry Guide
November 2012 · MarketLine
Pharmaceuticals - North America (NAFTA) Industry Guide is an essential resource for top-level data and analysis covering the Pharmaceuticals industry in each of the North American Free Trade Agreement (United States, Canada, and Mexico) countries. € 599,00
Pharmaceuticals - Scandinavia Industry Guide
November 2012 · MarketLine
Pharmaceuticals - Scandinavia Industry Guide is an essential resource for top-level data and analysis covering the Pharmaceuticals industry in each of the Scandinavian (Denmark, Norway and Sweden) countries. The report includes easily comparable data ... € 599,00
Pharmaceuticals - Top 5 Emerging Markets Industry Guide
November 2012 · MarketLine
Pharmaceuticals - Top 5 Emerging Markets Industry Guide is an essential resource for top-level data and analysis covering the Pharmaceuticals industry in each of the Top 5 Emerging markets (Brazil, China, India, Mexico and South Africa). € 749,00
Pharmaceuticals: Global Industry Almanac
November 2012 · MarketLine
Pharmaceuticals: Global Industry Almanac is an essential resource for top-level data and analysis covering the Pharmaceuticals industry. It includes detailed data on market size and segmentation, textual analysis of the key trends. € 2.199,00
Pharmaceuticals: Global Industry Guide
November 2012 · MarketLine
Pharmaceuticals: Global Industry Guide is an essential resource for top-level data and analysis covering the Pharmaceuticals industry. It includes detailed data on market size and segmentation, textual analysis of the key trends. € 1.099,00
Pharmaceuticals in Canada
November 2012 · MarketLine
Pharmaceuticals in Canada industry profile provides top-line qualitative and quantitative summary information including: market size (value 2007-11, and forecast to 2016). € 259,00
Pharmaceuticals in the United States
November 2012 · MarketLine
Pharmaceuticals in the United States industry profile provides top-line qualitative and quantitative summary information including: market size (value 2007-11, and forecast to 2016). € 259,00
Pharmaceuticals in China
November 2012 · MarketLine
Pharmaceuticals in China industry profile provides top-line qualitative and quantitative summary information including: market size (value 2007-11, and forecast to 2016). € 259,00
Pharmaceuticals in Japan
November 2012 · MarketLine
Pharmaceuticals in Japan industry profile provides top-line qualitative and quantitative summary information including: market size (value 2007-11, and forecast to 2016). € 259,00
Pharmaceuticals in Belgium
November 2012 · MarketLine
Pharmaceuticals in Belgium industry profile provides top-line qualitative and quantitative summary information including: market size (value 2007-11, and forecast to 2016). € 259,00
Pharmaceuticals in France
November 2012 · MarketLine
Pharmaceuticals in France industry profile provides top-line qualitative and quantitative summary information including: market size (value 2007-11, and forecast to 2016). € 259,00
Pharmaceuticals in Germany
November 2012 · MarketLine
Pharmaceuticals in Germany industry profile provides top-line qualitative and quantitative summary information including: market size (value 2007-11, and forecast to 2016). € 259,00
Pharmaceuticals in Italy
November 2012 · MarketLine
Pharmaceuticals in Italy industry profile provides top-line qualitative and quantitative summary information including: market size (value 2007-11, and forecast to 2016). € 259,00
Pharmaceuticals in the Netherlands
November 2012 · MarketLine
Pharmaceuticals in the Netherlands industry profile provides top-line qualitative and quantitative summary information including: market size (value 2007-11, and forecast to 2016). € 259,00
Pharmaceuticals in Spain
November 2012 · MarketLine
Pharmaceuticals in Spain industry profile provides top-line qualitative and quantitative summary information including: market size (value 2007-11, and forecast to 2016). € 259,00
Pharmaceuticals in the United Kingdom
November 2012 · MarketLine
Pharmaceuticals in the United Kingdom industry profile provides top-line qualitative and quantitative summary information including: market size (value 2007-11, and forecast to 2016). € 259,00
Global Pharmaceuticals
November 2012 · MarketLine
Global Pharmaceuticals industry profile provides top-line qualitative and quantitative summary information including: market size (value 2007-11, and forecast to 2016). € 259,00
Pharmaceuticals in Asia-Pacific
November 2012 · MarketLine
Pharmaceuticals in Asia-Pacific industry profile provides top-line qualitative and quantitative summary information including: market size (value 2007-11, and forecast to 2016). € 259,00
Pharmaceuticals in Europe
November 2012 · MarketLine
Pharmaceuticals in Europe industry profile provides top-line qualitative and quantitative summary information including: market size (value 2007-11, and forecast to 2016). € 259,00
Pharmaceuticals in Singapore
November 2012 · MarketLine
Pharmaceuticals in Singapore industry profile provides top-line qualitative and quantitative summary information including: market size (value 2007-11, and forecast to 2016). € 259,00
Pharmaceuticals in New Zealand
November 2012 · MarketLine
Pharmaceuticals in New Zealand industry profile provides top-line qualitative and quantitative summary information including: market size (value 2007-11, and forecast to 2016). € 259,00
Pharmaceuticals in Mexico
November 2012 · MarketLine
Pharmaceuticals in Mexico industry profile provides top-line qualitative and quantitative summary information including: market size (value 2007-11, and forecast to 2016). € 259,00
Pharmaceuticals in Brazil
November 2012 · MarketLine
Pharmaceuticals in Brazil industry profile provides top-line qualitative and quantitative summary information including: market size (value 2007-11, and forecast to 2016). € 259,00
Pharmaceuticals in South Africa
November 2012 · MarketLine
Pharmaceuticals in South Africa industry profile provides top-line qualitative and quantitative summary information including: market size (value 2007-11, and forecast to 2016). € 259,00
Pharmaceuticals in Hungary
November 2012 · MarketLine
Pharmaceuticals in Hungary industry profile provides top-line qualitative and quantitative summary information including: market size (value 2007-11, and forecast to 2016). € 259,00
Pharmaceuticals in Russia
November 2012 · MarketLine
Pharmaceuticals in Russia industry profile provides top-line qualitative and quantitative summary information including: market size (value 2007-11, and forecast to 2016). € 259,00
Pharmaceuticals in the Czech Republic
November 2012 · MarketLine
Pharmaceuticals in the Czech Republic industry profile provides top-line qualitative and quantitative summary information including: market size (value 2007-11, and forecast to 2016). € 259,00
Pharmaceuticals in Denmark
November 2012 · MarketLine
Pharmaceuticals in Denmark industry profile provides top-line qualitative and quantitative summary information including: market size (value 2007-11, and forecast to 2016). € 259,00
Pharmaceuticals in Norway
November 2012 · MarketLine
Pharmaceuticals in Norway industry profile provides top-line qualitative and quantitative summary information including: market size (value 2007-11, and forecast to 2016). € 259,00
Pharmaceuticals in Sweden
November 2012 · MarketLine
Pharmaceuticals in Sweden industry profile provides top-line qualitative and quantitative summary information including: market size (value 2007-11, and forecast to 2016). € 259,00
Pharmaceuticals in Australia
November 2012 · MarketLine
Pharmaceuticals in Australia industry profile provides top-line qualitative and quantitative summary information including: market size (value 2007-11, and forecast to 2016). € 259,00
Pharmaceuticals in Taiwan
November 2012 · MarketLine
Pharmaceuticals in Taiwan industry profile provides top-line qualitative and quantitative summary information including: market size (value 2007-11, and forecast to 2016). € 259,00
Pharmaceuticals in South Korea
November 2012 · MarketLine
Pharmaceuticals in South Korea industry profile provides top-line qualitative and quantitative summary information including: market size (value 2007-11, and forecast to 2016). € 259,00
Pharmaceuticals in India
November 2012 · MarketLine
Pharmaceuticals in India industry profile provides top-line qualitative and quantitative summary information including: market size (value 2007-11, and forecast to 2016). € 259,00
Pharmaceuticals in Poland
November 2012 · MarketLine
Pharmaceuticals in Poland industry profile provides top-line qualitative and quantitative summary information including: market size (value 2007-11, and forecast to 2016). € 259,00
Options

